SNDX-5613

Menin Inhibitor
PreClin
Phase 1
Phase 2
Pivotal
Indication(s)

Axatilimab (SNDX-6352)

CSF-1R mAB
PreClin
Phase 1
Phase 2
Pivotal
Indication(s)

Entinostat (SNDX-275)

Class 1 HDAC Inhibitor
PreClin
Phase 1
Phase 2
Pivotal
Indication(s)